(FSEP) FT Cboe Vest U.S. Equity - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US33740U3077
FSEP: FLEX Options, S&P 500, Buffer, ETF, Defined Outcome
The FT Cboe Vest U.S. Equity Buffer ETF - September (BATS:FSEP) is an exchange-traded fund that employs a defined outcome strategy, primarily investing in FLEX Options that track the performance of the SPDR S&P 500 ETF Trust. FLEX Options are exchange-traded, customizable contracts that allow investors to tailor key terms such as exercise prices, styles, and expiration dates to suit their needs.
As a non-diversified fund, FSEPs investment approach is centered around mitigating potential losses while still capturing upside potential, up to a certain cap, by utilizing the FLEX Options. This strategy is designed to provide a buffer against the first 9.7% (as per the funds objective for the September series) of losses in the underlying SPDR S&P 500 ETF Trust, hence the name Buffer ETF.
Analyzing the funds recent performance and technical indicators, we observe that the last price is $46.71, slightly above its 20-day Simple Moving Average (SMA) of $46.62, indicating a potential bullish trend. The 50-day and 200-day SMAs stand at $45.35 and $45.45, respectively, suggesting a longer-term uptrend. The Average True Range (ATR) is 0.34, or 0.73%, indicating relatively low volatility.
Given the current technical setup and fundamental data, including an Assets Under Management (AUM) of $816.14 million, we can forecast that FSEP is likely to continue its upward trajectory, potentially reaching the 52-week high of $47.07, if the underlying SPDR S&P 500 ETF Trust continues to perform well. However, the buffer feature is designed to protect against downside risk, so significant losses are mitigated. Investors should closely monitor the funds tracking performance relative to its underlying index and adjust their strategies accordingly.
Based on the technical and fundamental analysis, a potential trading strategy could involve buying FSEP on dips towards the 20-day SMA, with a target near the 52-week high, while keeping a close eye on the overall market conditions and the performance of the SPDR S&P 500 ETF Trust. Its essential to set appropriate stop-loss levels, potentially around the 50-day SMA, to manage risk.
Additional Sources for FSEP ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
FSEP ETF Overview
Market Cap in USD | 816m |
Category | Defined Outcome |
TER | 0.85% |
IPO / Inception | 2020-09-18 |
FSEP ETF Ratings
Growth Rating | 70.4 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -4.42 |
Analysts | - |
Fair Price Momentum | 46.14 USD |
Fair Price DCF | - |
FSEP Dividends
Currently no dividends paidFSEP Growth Ratios
Growth Correlation 3m | 93.4% |
Growth Correlation 12m | 52.4% |
Growth Correlation 5y | 89.4% |
CAGR 5y | 10.73% |
CAGR/Max DD 5y | 0.78 |
Sharpe Ratio 12m | 1.01 |
Alpha | -0.20 |
Beta | 0.531 |
Volatility | 7.06% |
Current Volume | 12.9k |
Average Volume 20d | 8.1k |
As of July 01, 2025, the stock is trading at USD 48.01 with a total of 12,925 shares traded.
Over the past week, the price has changed by +2.03%, over one month by +3.28%, over three months by +7.76% and over the past year by +9.63%.
Yes. Based on ValueRay´s Analyses, FT Cboe Vest U.S. Equity (BATS:FSEP) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 70.37 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FSEP is around 46.14 USD . This means that FSEP is currently overvalued and has a potential downside of -3.9%.
FT Cboe Vest U.S. Equity has no consensus analysts rating.
According to our own proprietary Forecast Model, FSEP FT Cboe Vest U.S. Equity will be worth about 52 in July 2026. The stock is currently trading at 48.01. This means that the stock has a potential upside of +8.31%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 52 | 8.3% |